An NMR based panorama of the heterogeneous biology of acute respiratory distress syndrome (ARDS) from the standpoint of metabolic biomarkers

• Published in: NMR in biomedicine Vol. 33; no. 2; pp. e4192 - n/a
• Main Authors: Viswan, Akhila, Singh, Chandan, Kayastha, Arvind M., Azim, Afzal, Sinha, Neeraj
• Format: Journal Article
• Language: English
• Published: England Wiley Subscription Services, Inc 01.02.2020
• Subjects: Animals; ARDS; Biological products; Biology; biomarker; Biomarkers; Biomarkers - metabolism; Biometrics; chemometrics; Critical Care; Diagnostic systems; Etiology; Heterogeneity; Humans; Magnetic Resonance Spectroscopy; Medical prognosis; Metabolism; Metabolites; Metabolomics; Multivariate Analysis; NMR; Nuclear magnetic resonance; phenotype; Phenotypes; Physiology; respiratory diseases; Respiratory distress syndrome; Respiratory Distress Syndrome - diagnostic imaging; Respiratory Distress Syndrome - epidemiology; Respiratory Distress Syndrome - metabolism; Respiratory Distress Syndrome - physiopathology; Reviews; phenotype; NMR; chemometrics; metabolomics; critical care; respiratory diseases; biomarker; ARDS
• ISSN: 0952-3480; 1099-1492
• DOI: 10.1002/nbm.4192

Acute respiratory distress syndrome (ARDS), manifested by intricate etiology and pathophysiology, demands careful clinical surveillance due to its high mortality and imminent life support measures. NMR based metabolomics provides an approach for ARDS which culminates from a wide spectrum of illness thereby confounding early manifestation and prognosis predictors. 1H NMR with its manifold applications in critical disease settings can unravel the biomarker of ARDS thus holding potent implications by providing surrogate endpoints of clinical utility. NMR metabolomics which is the current apogee platform of omics trilogy is contributing towards the possible panacea of ARDS by subsequent validation of biomarker credential on larger datasets. In the present review, the physiological derangements that jeopardize the whole metabolic functioning in ARDS are exploited and the biomarkers involved in progression are addressed and substantiated. The following sections of the review also outline the clinical spectrum of ARDS from the standpoint of NMR based metabolomics which is an emerging element of systems biology. ARDS is the main premise of intensivists textbook, which has been thoroughly reviewed along with its incidence, progressive stages of severity, new proposed diagnostic definition, and the preventive measures and the current pitfalls of clinical management. The advent of new therapies, the need for biomarkers, the methodology and the contemporary promising approaches needed to improve survival and address heterogeneity have also been evaluated. The review has been stepwise illustrated with potent biometrics employed to selectively pool out differential metabolites as diagnostic markers and outcome predictors. The following sections have been drafted with an objective to better understand ARDS mechanisms with predictive and precise biomarkers detected so far on the basis of underlying physiological parameters having close proximity to diseased phenotype. The aim of this review is to stimulate interest in conducting more studies to help resolve the complex heterogeneity of ARDS with biomarkers of clinical utility and relevance. ARDS directed lung injury stipulates mechanical ventilation in ICU patients. The complex etiology and complexity demands mirroring the underlying pathophysiology and aberrant metabolism to identify at risk ARDS patients. NMR based metabolomics proves to be dynamic real time diagnotic measure to snapshot the metabolic perturbation and ARDS associated biomarkers by the targeted and tailored approach.